Bitter orange (Citrus aurantium L.) extract subchronic 90-day safety study in rats.

about

Bitter orange (Citrus aurantium L.) extract subchronic 90-day safety study in rats.

Item

http://www.wikidata.org/entity/Q47568260

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

Bitter orange (Citrus aurantium L.) extract subchronic 90-day safety study in rats.

@en

Bitter orange

@nl

type

Item

label

Bitter orange (Citrus aurantium L.) extract subchronic 90-day safety study in rats.

@en

Bitter orange

@nl

prefLabel

Bitter orange (Citrus aurantium L.) extract subchronic 90-day safety study in rats.

@en

Bitter orange

@nl

P1476

Bitter orange (Citrus aurantium L.) extract subchronic 90-day safety study in rats.

@en

P2093

A Kale

http://www.w3.org/2001/XMLSchema#string

B Sowmya

http://www.w3.org/2001/XMLSchema#string

C C Magar

http://www.w3.org/2001/XMLSchema#string

N S Deshmukh

http://www.w3.org/2001/XMLSchema#string

S J Stohs

http://www.w3.org/2001/XMLSchema#string

P2860

A review of the human clinical studies involving Citrus aurantium (bitter orange) extract and its primary protoalkaloid p-synephrine

A review of the receptor-binding properties of p-synephrine as related to its pharmacological effects

A Review of Natural Stimulant and Non-stimulant Thermogenic Agents

Selective activation of beta3-adrenoceptors by octopamine: comparative studies in mammalian fat cells

Animal behavioral methods in neurotoxicity assessment: SGOMSEC joint report.

Developmental toxicity of Citrus aurantium in rats

Citrus aurantium, an ingredient of dietary supplements marketed for weight loss: current status of clinical and basic research.

Safety and efficacy of citrus aurantium for weight loss.

Chromatographic and electrophoretic methods for the analysis of phenethylamine [corrected] alkaloids in Citrus aurantium.

The safety of Citrus aurantium (bitter orange) and its primary protoalkaloid p-synephrine.

P304

598-613

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.TOXREP.2017.11.002

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-11-12T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29214145

http://www.w3.org/2001/XMLSchema#string

P932

5686423

http://www.w3.org/2001/XMLSchema#string